MSG enters with agreement to mfg, market 2-DG
MSN Laboratories has signed a license agreement with the Defence Research and Development Organization (DRDO) for the manufacturing, distribution and marketing of Covid-19 drug 2-DG in India.
MSN said it will be launching the drug under the brand name MSN 2D in sachet form as a twice a day product in strength of 2.24 g.
Recent Posts
Experts Warn of Global Threat from Chronic Wasting Disease
Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…
CDC Reschedules Vaccine Advisory Meeting to April 15-16
The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…
India’s Specialty Chemicals Rebound, Pharma Exports Surge
India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…
Gut Bacteria: The Hidden Key to Human Brain Evolution
The evolution of the human brain is one of the most fascinating topics in science.…
Obesity and Sleep Apnea: Warning Signs and Prevention Tips
Sleep apnea is a common yet serious sleep disorder that affects millions of people worldwide.…
Harmful Bacteria in the Human Body: Risks and Prevention
The human body is home to trillions of bacteria, many of which are beneficial for…